Multiomic Health

United Kingdom - London

• 05/05/2023
• Seed
• $6,307,750

Multiomic Health is a data-centric therapeutics venture, writing the latest chapter of the precision medicine story by tackling a global, trillion dollar healthcare problem: metabolic syndrome-related conditions (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver).

Our mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently dominating this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.

Related People

Robert ThongCo Founder

United Kingdom - London, England

30+ years’ experience of business leadership and strategic consulting for bioscience and healthcare organisations across 15 countries in Europe, the United States and Asia. Now focused on bioscience startups majoring in business model development, B2B partnerships, growth strategy and investor risk mitigation. Published author on biopharma R&D alliances and visiting lecturer at University of Cambridge and University College London.

LinkedIn https://www.linkedin.com/in/robertthong/